Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: OTIS Humira Pregnancy Registry
This document reports the completion status of the OTIS Humira Pregnancy Registry (NCT01086059), summarizing data collection on pregnancy ou…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
A pregnancy exposure registry studying safety of ustekinumab (Stelara) and guselkumab (Tremfya) during pregnancy in autoimmune diseases; the…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: OTIS Cimzia Pregnancy Registry
This clinical trial registry update describes the OTIS Cimzia Pregnancy Registry sponsored by UC San Diego. It tracks pregnancy outcomes for…
-
CLINICAL_TRIALS trial_result · 2025-01-21Clinical Trial Update: The Clinical Efficacy and Influence Factors of Individualized Treatment of Ustekinumab in Crohn's Disease
A completed clinical trial evaluating the efficacy of individualized ustekinumab treatment in Crohn's disease. The study investigates factor…
-
CLINICAL_TRIALS trial_result · 2025-01-21Clinical Trial Update: Interest of the Dosage of Adalimumab Serum Levels in Crohn's Disease Patients for Prevention of Postoperative Recurrence [NA]
This clinical trial evaluated whether adalimumab serum levels influence prevention of postoperative recurrence in Crohn's disease and has be…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease
This clinical trial update notes recruitment status for evaluating the efficacy and safety of upadacitinib in inflammatory bowel disease, in…
-
FDA approval · 2025-01-15FDA Approved: OMVOH — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for OMVOH (mirikizumab-MRKZ) submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis. [Phase 1]
Phase 1 study using a fluorescently labeled form of ustekinumab (Ustekinumab-800CW) to visualize and quantify how the drug distributes in in…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Long-term Remission After Ileorectal Anastomosis in Crohn's Disease.
A clinical trial update reports long-term remission following ileorectal anastomosis in Crohn's disease.
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: MRE as a Screening Tool for axSpA in IBD
This trial evaluated magnetic resonance enterography as a screening method for axial spondyloarthritis in Crohn disease. The study (NCT03817…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: Unraveling the Blood Microbiome in Postoperative Recurrence of Crohn's Disease
An Erasmus Medical Center trial registration exploring the role of the blood microbiome in postoperative recurrence of Crohn's disease. The …
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Autoimmune Protocol Diet and Inflammatory Bowel Disease [NA]
The clinical trial evaluating the autoimmune protocol diet for inflammatory bowel disease has completed, and results have been posted. Condi…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease. [Phase 4]
A Phase 4 trial sponsored by the University of Manitoba is evaluating bowel preparation for colonoscopy in people with Crohn's disease or ul…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Study on the Long-Term Risk of Recurrence of Anoperineal Fistula in Crohn's Disease
This clinical trial update notes an ongoing study sponsored by University Hospital, Toulouse, evaluating the long-term risk of recurrence of…
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease [Phase 4]
This update describes ongoing Phase 4 research on de-escalating anti-TNF therapy for inflammatory bowel disease, including Crohn's disease a…
-
CLINICAL_TRIALS research · 2025-01-03Clinical Trial Update: Chronic Care Model on Symptom Status, Stress and Quality of Life in Individuals With Inflammatory Bowel Disease [NA]
This clinical trial update describes the status of a study evaluating a chronic care model's impact on symptoms, stress, and quality of life…
-
CLINICAL_TRIALS research · 2025-01-01Clinical Trial Update: Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease [Phase 1]
A Phase 1 clinical trial update for TQH3906 capsules in adults with moderately to severely active ulcerative colitis or Crohn's disease, wit…
-
CLINICAL_TRIALS other · 2025-01-01Clinical Trial Update: Early Inflammatory Bowel Disease Progression
A clinical trial update shows recruiting status for a study on inflammatory bowel diseases, including Crohn's disease and ulcerative colitis…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease [Phase 3]
Phase 3 results for Mirikizumab in Crohn's disease have been posted following completion of the trial. The status is completed, with results…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Study on the Treatment of Anal Fistulas Using Alofisel Versus Fat Autologous Stem Cells
This ongoing clinical trial compares Alofisel (darvadstrocel) to autologous fat-derived stem cells for treating anal fistulas in Crohn's dis…
-
FDA approval · 2024-12-26FDA Approved: WEZLANA — Supplemental Application (Nuvaila Limited)
The FDA approved a supplemental Biologics License Application for WEZLANA (ustekinumab-auub) submitted by Nuvaila Limited.
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: Evaluation of the Efficacy and Safety of Endoscopic Dilatation and Biological Therapy in Intestinal Stenosis Due to CD
This clinical trial update details an ongoing study evaluating endoscopic dilatation combined with biological therapy for Crohn's disease-re…
-
FDA approval · 2024-12-20FDA Approved: USTEKINUMAB-TTWE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for USTEKINUMAB-TTWE from Quallent Pharmaceuticals Health LLC. This action confirms additional regul…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
A Massachusetts General Hospital-sponsored study is recruiting to assess the risk of developing inflammatory bowel disease, including ulcera…
-
FDA approval · 2024-12-18FDA Approved: IDACIO — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for IDACIO (adalimumab-aacf) from Fresenius Kabi USA, LLC.